The company's inventory is rising every quarter. From the interim report of 20 17 to the interim report of 20 18, the inventory value has doubled. The overstocked inventory shows that the company's sales have encountered resistance. However, the gross profit margin of the company's products has been increasing year by year from 20 16 to 20 18, from 42.88% in 20 16 to 48.58% in 20 18. This contradictory phenomenon is confusing. Therefore, we can only guess that the company reduced the unit operating cost by increasing production and overstocking inventory, thus increasing the gross profit margin, and may also take some "special transactions" to expand the company's turnover. At the same time, we found that the wealth management products under the company's "other current assets" decreased from 520 million at the beginning of 20 18 to 233 million at present, which indirectly indicated that the company's demand for funds was increasing. But if the company's products rely on high gross profit and sell well, this should not happen.

1. Shares have two meanings. First of all, shares are an integral part of the total capital of a joint stock limited company. Second, stocks are an integral part of the value of listed stocks.

Second, what is the ownership structure?

In a corporate governance structure, there are two main relationships that shareholders have to deal with: one is the relationship between shareholders; The second is the relationship between shareholders and executives, that is, the ownership structure of a single company. In practice, a controlling shareholder is usually a shareholder of several or even dozens of companies, so how to construct the relationship between companies is very important.

Nanjing jianyou biochemical pharmaceutical co., ltd.

Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. mainly produces heparin sodium and low molecular weight heparin series products, located in Nanjing High-tech Industrial Development Zone. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. currently covers an area of more than 40 mu; The company is a high-tech enterprise in Jiangsu and Nanjing, and the president of heparin sodium branch of China Chamber of Commerce for Import and Export of Medicines and Health Products. The company's production and sales are among the best in China, of which heparin sodium accounts for about 20% of the world. Our products have passed GMP certification in China, FDA certification in the United States and EDQM certification in the European Union. Mainly exported to Europe and America, and has long-term cooperative relations with many Fortune 500 pharmaceutical companies.